TOPELIA THERAPEUTICS Trademark

Trademark Overview

On Tuesday, February 2, 2021, a trademark application was filed for TOPELIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TOPELIA THERAPEUTICS trademark a serial number of 90505371. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2024. This trademark is owned by Progenabiome, LLC. The TOPELIA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of COVID 19, Corona viruses, Influenza, Autism, Alzheimer's, Parkinson's Disease, Multiple Sclerosis, and Epstein-Barr Virus
topelia therapeutics

General Information

Serial Number90505371
Word MarkTOPELIA THERAPEUTICS
Filing DateTuesday, February 2, 2021
Status700 - REGISTERED
Status DateTuesday, June 11, 2024
Registration Number7414142
Registration DateTuesday, June 11, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of COVID 19, Corona viruses, Influenza, Autism, Alzheimer's, Parkinson's Disease, Multiple Sclerosis, and Epstein-Barr Virus
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 6, 2021
Primary Code005
First Use Anywhere DateSunday, January 31, 2021
First Use In Commerce DateSunday, January 31, 2021

Trademark Owner History

Party NameProgenabiome, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressVentura, CA 93003
Party NameProgenabiome, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressVentura, CA 93003
Party NameProgenabiome, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressVentura, CA 93003

Trademark Events

Event DateEvent Description
Friday, February 5, 2021NEW APPLICATION ENTERED
Thursday, May 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 30, 2021ASSIGNED TO EXAMINER
Wednesday, February 23, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 2, 2021NON-FINAL ACTION WRITTEN
Thursday, September 2, 2021NON-FINAL ACTION E-MAILED
Thursday, September 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 28, 2022ASSIGNED TO LIE
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 16, 2022ASSIGNED TO EXAMINER
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2022SOU EXTENSION 1 FILED
Wednesday, November 30, 2022SOU EXTENSION 1 GRANTED
Wednesday, June 14, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, December 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 16, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, May 16, 2023USE AMENDMENT FILED
Wednesday, June 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 8, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Saturday, June 17, 2023SU - NON-FINAL ACTION - WRITTEN
Saturday, June 17, 2023NON-FINAL ACTION E-MAILED
Saturday, June 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 8, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, May 6, 2024ASSIGNED TO LIE
Monday, May 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 7, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 7, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 11, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 11, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, December 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

therapeutics topelia multiple disease parkinson sclerosis epstein virus barr alzheimer autism treatment